Since our inception in 2004, our steadfast focus has been providing research grants to the worlds’ leading scientists researching Alzheimer’s disease. We are honored to work with scientists who are passionate in their pursuit to rid our world of this debilitating disease.

Many of the funded projects have resulted in significant breakthroughs in developing a better understanding of Alzheimer’s disease and getting closer to a cure.

Jean-Pierre Roussarie, | 2020

Regulation by Apolipoprotein E of Selective Neuronal Vulnerability to Alzheimer’s Disease

Guojun Bu, | 2020

Counteracting Pathogenic Events in Alzheimer’s Disease with Peripheral or Central Apolipoprotein E

Randall Bateman, | 2020

Assessing the Added Diagnostic Value of Peripheral Apolipoprotein E Protein Levels in Current Blood-Based Biomarker Assays for Central Nervous System Amyloidosis

Giuseppina Tesco, | 2020

In Vivo Characterization of a Loss-of-Function GGA3 Rare Variant Associated with Alzheimer’s Disease

Krista L. Moulder, | 2020

Characterization of Alzheimer’s Disease Molecular Biomarker Profiles Throughout the Pathobiological Continuum

Takahisa Kanekiyo, Guojun Bu, | 2020

ABCA7 Loss of Function in Aging and Alzheimer’s Disease

Ali Ezzati, Richard Lipton, | 2020

Improving Alzheimer’s Disease Clinical Trials’ Design by Machine Learning Models

Berislav Zlokovic, | 2019

Molecular Signatures of APOE-Mediated Blood-Brain Barrier Dysfunction Causing Neuronal and Synaptic Dysfunction

Shirley Wray,

An Innovative Study of the Pupil Light Reflex in Alzheimer’s Disease

Howard L. Weiner, Laura Cox, | 2019

Targeting the Microbiome and Microglia in Alzheimer’s Disease

Alejandra Camacho-Soto, Brad Racette, Susan Searles Nielsen, | 2019

Harnessing Big Data to Understand Alzheimer’s Disease Risk

Krista L. Moulder, | 2019

Characterization of Alzheimer’s Disease Molecular Biomarker Profiles Throughout the Pathobiological Continuum

Funded Projects

The science that has advanced our understanding of Alzheimer's disease

Regulation by Apolipoprotein E of Selective Neuronal Vulnerability to Alzheimer’s Disease

Counteracting Pathogenic Events in Alzheimer’s Disease with Peripheral or Central Apolipoprotein E

Assessing the Added Diagnostic Value of Peripheral Apolipoprotein E Protein Levels in Current Blood-Based Biomarker Assays for Central Nervous System Amyloidosis

In Vivo Characterization of a Loss-of-Function GGA3 Rare Variant Associated with Alzheimer’s Disease

Characterization of Alzheimer’s Disease Molecular Biomarker Profiles Throughout the Pathobiological Continuum

ABCA7 Loss of Function in Aging and Alzheimer’s Disease

Improving Alzheimer’s Disease Clinical Trials’ Design by Machine Learning Models

Molecular Signatures of APOE-Mediated Blood-Brain Barrier Dysfunction Causing Neuronal and Synaptic Dysfunction

An Innovative Study of the Pupil Light Reflex in Alzheimer’s Disease

Targeting the Microbiome and Microglia in Alzheimer’s Disease

Harnessing Big Data to Understand Alzheimer’s Disease Risk

Characterization of Alzheimer’s Disease Molecular Biomarker Profiles Throughout the Pathobiological Continuum